Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.
about
Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite proteinIncreased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageMultistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaquesBoosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccineMalaria vaccines: identifying Plasmodium falciparum liver-stage targetsInterferon-γ: The Jekyll and Hyde of MalariaDiscovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine DevelopmentA sporozoite asparagine-rich protein controls initiation of Plasmodium liver stage developmentComplex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell AntigensIdentification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library.Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccineWhy functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines.Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmidsVaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus.Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice.A role for cytokines in potentiation of malaria vaccines through immunological modulation of blood stage infection.Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNAAltering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune responseChallenges and opportunities for development of an AIDS vaccine.Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodiesDifferential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis.Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trialsCD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice.Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture.Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice.Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity.Plasmodium immunomics.Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates.A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.A small peptide (CEL-1000) derived from the beta-chain of the human major histocompatibility complex class II molecule induces complete protection against malaria in an antigen-independent manner
P2860
Q24514954-5B4FB530-C82B-442F-B9BB-63A906AB6BADQ24531468-BA487DD9-8059-43B1-B355-619BAC1D069BQ24548638-C12C4D6D-DAF3-48F7-B700-4D4269F83235Q24650662-A5F806B5-3B5B-4A94-9073-926414B05FC1Q26781372-8A037894-CED8-4A9B-AB48-9E2B9A8BDDA0Q26782988-D851206D-920D-4610-9C20-0F335F63D1D9Q27972709-B5922545-9A88-4912-8DC9-9693C4548482Q27973897-00745021-060E-4088-87E0-F4372B80E72CQ28551311-38C5EB8D-F3DD-4132-925A-54BF97F29590Q30654793-11511405-BCBC-4DDA-B9B5-56235F45EFD9Q30814677-7FF4F90C-2FA0-4594-A6C9-3DB8A5B10CAEQ33214292-313FC4BD-DA12-406F-8E5C-CE67B2BB4EE4Q33587443-1053467A-67C6-4435-8770-63D14DAD8A7FQ33757015-28A6D15E-956B-4BFB-BCFE-DDFE29B0EBA4Q33761524-581C2119-FBD7-4404-9514-E52796BD8EE4Q33767207-287E4494-3C97-4B78-96B3-CA6B63C9EB0FQ33772060-600D5047-C9EB-464B-AD2A-A62593824BB9Q33776098-0D517700-B203-42C1-912E-3E0C7E37B86FQ33783688-1B6F5045-8ECC-452F-B0A2-2C2F1A817B4FQ33784968-C881938E-1DF1-4372-A17F-7DF65DBCA5BCQ33785071-65E28C6F-CAB6-4860-835F-477A15E03A72Q33825265-E1BF4899-6E37-4DD2-BF66-6C1C37A5864DQ33942996-E1AF2D40-677E-467A-9435-04C52D392793Q34000822-8B88FF51-9239-48D4-803C-EB79C890A65AQ34000833-87A3A42A-DD16-4282-B4B9-59418697E00FQ34001568-6EC0F27D-54E6-4357-94CB-4485614363DDQ34002308-28DD0ADD-1CF7-430A-A8F7-B270548130ECQ34002934-B4F158DD-941B-4516-BDB7-1D1749B65C36Q34003047-7B96C2C5-CAA6-47E4-9976-63A81B486A2CQ34004723-BD717DD3-E594-41F1-B59D-69AFBCFD2B2EQ34006127-F8C9039F-CB36-4DC1-B693-4B3ABBD30F9EQ34006411-6E4744BD-2484-41BC-89E4-C85B4B488883Q34007894-0BD693A2-B440-4C34-9051-57045BB36ADBQ34009561-5F7532E9-04AB-43B5-BF84-96DF326B5186Q34126483-B19E3690-BD72-44A7-9470-D98FF0B457F6Q34280935-2F7BC5F9-28B4-465D-A9B4-3DF95058F5D7Q34419934-2463F8B5-B389-4A02-B364-E2BB20E83158Q34778655-65FA8772-EA67-430E-8641-E52CC6905CA6Q35122498-B61046DF-8EB6-4944-B9E2-EBFAC1324F93Q35124515-4A91C45E-CFCB-4CEE-9A4C-51FA4EEC548C
P2860
Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Circumventing genetic restrict ...... tric oxide-dependent immunity.
@ast
Circumventing genetic restrict ...... tric oxide-dependent immunity.
@en
type
label
Circumventing genetic restrict ...... tric oxide-dependent immunity.
@ast
Circumventing genetic restrict ...... tric oxide-dependent immunity.
@en
prefLabel
Circumventing genetic restrict ...... tric oxide-dependent immunity.
@ast
Circumventing genetic restrict ...... tric oxide-dependent immunity.
@en
P2093
P2860
P356
P1476
Circumventing genetic restrict ...... tric oxide-dependent immunity.
@en
P2093
Charoenvit Y
Hedstrom RC
P2860
P304
P356
10.1084/JEM.183.4.1739
P407
P577
1996-04-01T00:00:00Z